Literature DB >> 17048670

[The nephrotoxicity in rats caused by Longdan Xiegan decoction].

Na Zhang1, Ming Xie.   

Abstract

OBJECTIVE: To observe the renal injury in rats induced by Longdan Xiegan decoction (LDXGD) containing different dosages Aristolochia manshriensis.
METHOD: SD rats were divided into four groups at random, and were fed with three kinds of LDXGD 13, 14.5, 17.5 g x kg(-1) (containing respectively A. manshriensis 1.5, 3, 6 g x kg(-1)) and distilled water respectively for 12 weeks. Renal functional parameters on 4,8,12 w were determined and changes of histomorphology in rats on the end of experiment were observed. RESULT: The LDXGD containing low dose (1.5 g x kg(-1)) A. manshriensis did't induce significantly renal injury in rats during 12 weeks; the LDXGD containing midst dose(3 g x kg(-1)) A. manshriensis induced light damage of proximal convoluted tubule epithelial cells in rats during 12 weeks; the LDXGD containing high dose(6 g x kg(-1)) A. manshriensis induced significantly renal injury in rats after administed 4 weeks. Along with the lasting of administration, the degree of injury became more seriously. The main renal injury location was in proximal convoluted tubule.
CONCLUSION: The renal toxicity of LDXGD is correlated with the dose of A. manshriensis and the time of administration. The LDXGD containing low dose A. manshriensis has relative security. However, the LDXGD containing high dose A. manshriensis can induce renal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17048670

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Identification and determination of the major constituents in traditional Chinese medicine Longdan Xiegan Pill by HPLC-DAD-ESI-MS.

Authors:  Hui Liu; Juan Su; Xu Liang; Xi Zhang; Ya-Jun He; Hai-Qiang Huang; Ji Ye; Wei-Dong Zhang
Journal:  J Pharm Anal       Date:  2012-01-30

2.  Metabolomic analysis of complex chinese remedies: examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic Acid.

Authors:  Dong-Ming Tsai; Jaw-Jou Kang; Shoei-Sheng Lee; San-Yuan Wang; I-Lin Tsai; Guan-Yuan Chen; Hsiao-Wei Liao; Li Wei-Chu; Ching-Hua Kuo; Y Jane Tseng
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-31       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.